Currently holds a position at Ultragenyx Pharmaceutical Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Ultragenyx Pharmaceutical Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-08 | 2024-02-07 | PS Planned sale |
30,000
-5.3%
45.001,350,000 USD |
30,000 -5.3% | 45.00 | 1,350,000 USD | ||
2023-10-23 | 2023-10-19 | PS Planned sale |
47,853
-7.4%
33.521,604,033 USD |
47,853 -7.4% | 33.52 | 1,604,033 USD | ||
2023-01-03 | 2022-12-30 | PS Planned sale |
19,582
-3.5%
45.57892,352 USD |
19,582 -3.5% | 45.57 | 892,352 USD | ||
2021-03-03 | 2021-03-01 | PS Planned sale |
30,000
-1.3%
141.804,254,000 USD |
30,000 -1.3% | 141.80 | 4,254,000 USD | ||
2021-01-05 | 2021-01-04 | PS Planned sale |
30,000
-1.3%
136.904,107,000 USD |
30,000 -1.3% | 136.90 | 4,107,000 USD | ||
2020-11-04 | 2020-11-02 | PS Planned sale |
30,000
-1.3%
96.822,904,600 USD |
30,000 -1.3% | 96.82 | 2,904,600 USD | ||
2020-09-02 | 2020-09-01 | PS Planned sale |
30,000
-1.2%
82.632,478,900 USD |
30,000 -1.2% | 82.63 | 2,478,900 USD | ||
2020-07-15 | 2020-07-13 | PS Planned sale |
40,000
-1.6%
85.353,414,000 USD |
40,000 -1.6% | 85.35 | 3,414,000 USD | ||
2019-09-11 | 2019-09-11 | B Purchase |
5,000
+1.1%
43.63218,150 USD |
5,000 +1.1% | 43.63 | 218,150 USD | ||
2016-10-18 | 2016-10-14 | PS Planned sale |
6,515
-1.3%
61.97403,735 USD |
6,515 -1.3% | 61.97 | 403,735 USD | ||
2016-07-19 | 2016-07-15 | PS Planned sale |
13,550
-2.6%
50.61685,766 USD |
13,550 -2.6% | 50.61 | 685,766 USD | ||
2016-01-04 | 2015-12-31 | PS Planned sale |
605
-0.1%
114.6169,339 USD |
605 -0.1% | 114.61 | 69,339 USD | ||
2016-01-04 | 2015-12-31 | PS Planned sale |
2,702
-0.5%
113.83307,569 USD |
2,702 -0.5% | 113.83 | 307,569 USD | ||
2016-01-04 | 2015-12-31 | PS Planned sale |
2,191
-0.4%
112.91247,386 USD |
2,191 -0.4% | 112.91 | 247,386 USD | ||
2016-01-04 | 2015-12-30 | PS Planned sale |
2,600
-0.4%
116.31302,406 USD |
2,600 -0.4% | 116.31 | 302,406 USD | ||
2016-01-04 | 2015-12-30 | PS Planned sale |
5,465
-0.9%
114.61626,344 USD |
5,465 -0.9% | 114.61 | 626,344 USD | ||
2016-01-04 | 2015-12-30 | PS Planned sale |
2,837
-0.5%
113.30321,432 USD |
2,837 -0.5% | 113.30 | 321,432 USD | ||
2004-05-07 | 2004-05-06 |
Biomarin Pharmaceutical Inc
(BMRN)
|
B Purchase |
5,000
+23.7%
6.4832,400 USD |
5,000 +23.7% | 6.48 | 32,400 USD | |
2004-05-07 | 2004-05-06 |
Biomarin Pharmaceutical Inc
(BMRN)
|
B Purchase |
10,000
+90.0%
6.5065,000 USD |
10,000 +90.0% | 6.50 | 65,000 USD |